Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
MRTXThin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion
Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion
Mirati's Adagrasib Shows Promising Efficacy In KRAS Mutated Colorectal Cancer
MRTXMirati Therapeutics Q1 EPS $(3.40) Beats $(3.49) Estimate, Sales $709.00K Beat $160.00K Estimate
MRTXMirati Therapeutics: Q1 Earnings Insights
MRTXMirati Therapeutics (NASDAQ:MRTX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings Preview For Mirati Therapeutics
MRTXMirati Therapeutics (NASDAQ:MRTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement.
Analysts estimate that Mirati Therapeutics will report an earnings per share (EPS) of $-3.49.
